Edwards Lifesciences rose 5.5% after likewise topping Wall Street’s expectations for profit in the latest quarter. It said it saw strength across all its product groups, and it expects profit for the ...

GrafTech is a high-risk bet on graphite electrode recovery, with extended debt and pricing efforts offset by weak results.